Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4-Reference-Cited by-同舟云学术

Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4

Published:2018-02-06 Issue:2 Volume:21 Page:323-334
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Masetti Michele¹¹,Acquaviva Giorgia²¹,Visani Michela²,Tallini Giovanni²,Fornelli Adele³,Ragazzi Moira⁴,Vasuri Francesco⁵,Grifoni Daniela⁶,Di Giacomo Simone⁶,Fiorino Sirio⁷,Lombardi Raffaele¹,Tuminati David¹,Ravaioli Matteo⁸,Fabbri Carlo⁹,Bacchi-Reggiani Maria Letizia¹⁰,Pession Annalisa⁶,Jovine Elio¹²,de Biase Dario⁶²

Affiliation:

1. Surgery Unit, Azienda USL-Maggiore Hospital, Bologna, Italy

2. Department of Medicine (Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale) – Molecular Diagnostic Unit, Azienda USL di Bologna, University of Bologna School of Medicine, Bologna, Italy

3. Anatomic Pathology Unit, Azienda USL-Maggiore Hospital, Bologna, Italy

4. Anatomic Pathology Unit, Arcispedale Santa Maria Nuova – IRCCS, Reggio Emilia, Italy

5. Anatomic Pathology Unit, “F. Addarii” Institute of Oncology and Transplantation Pathology, S. Orsola-Malpighi University Hospital, Bologna, Italy

6. Department of Pharmacy and Biotechnology (Dipartimento di Farmacia e Biotecnologie) – Molecular Diagnostic Unit, Azienda USL di Bologna, University of Bologna, Bologna, Italy

7. Internal Medicine Unit, Maggiore Hospital, Bologna, Italy

8. Department of General Surgery and Transplantation, St. Orsola-Malpighi University Hospital, Bologna, Italy

9. Unit of Gastroenterology and Digestive Endoscopy, AUSL Bologna Bellaria-Maggiore Hospital, Bologna, Italy

10. Department of Medicine (Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale), Cardiology Unit, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference57 articles.

1. Long-term survival (5–20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions;Adham;Pancreas,2008

2. Histopathological identification of colon cancer with microsatellite instability;Alexander;The American Journal of Pathology,2001

3. p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells;Bailey;Oncogene,2016

4. Genomic analyses identify molecular subtypes of pancreatic cancer;Bailey;Nature,2016

5. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma;Biankin;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2002

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma;Journal of Clinical Medicine;2024-04-04

2. A novel method for detection of pancreatic Ductal Adenocarcinoma using explainable machine learning;Computer Methods and Programs in Biomedicine;2024-03

3. Identification and Validation of a Prognostic Signature of m 5 C-Related Genes for Esophageal Cancer;2023-10-23

4. Exploiting the molecular subtypes and genetic landscape in pancreatic cancer: the quest to find effective drugs;Frontiers in Genetics;2023-09-18

5. Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma;Frontiers in Oncology;2023-06-19